The 2 references without contexts in paper A. KOMAROV L., А. КОМАРОВ Л. (2017) “КЛИНИЧЕСКИЙ РАЗБОР ПАЦИЕНТА С РЕЦИДИВИРУЮЩИМИ ВЕНОЗНЫМИ ТРОМБОЭМБОЛИЧЕСКИМИ ОСЛОЖНЕНИЯМИ // CLINICAL DISCUSSION OF A PATIENT WITH RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS” / spz:neicon:aterotromboz:y:2017:i:2:p:79-94

22
Schulman S, Kearon C, Kakkar AK, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med, 2013 Feb 21, 368(8): 70918.
(check this in PDF content)
23
Raskob G, Ageno W, Cohen AT, et al. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study. Lancet Haematol, 2016 May, 3(5): e228-36.
(check this in PDF content)